Editor - Anthony Clifford Keech | The University of Sydney | 2037
ISSN: 2161-1165

Epidemiology: Open Access
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google scholar citation report
Citations : 1824

Epidemiology: Open Access received 1824 citations as per google scholar report

Epidemiology: Open Access peer review process verified at publons
Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Genamics JournalSeek
  • SafetyLit
  • Access to Global Online Research in Agriculture (AGORA)
  • Centre for Agriculture and Biosciences International (CABI)
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • CABI full text
  • Cab direct
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
Share This Page

Anthony Clifford Keech

Anthony Clifford Keech
Anthony Clifford Keech
The University of Sydney
Tel: +61-0-2-9562-5000
Fax: +61-0-2-9565-1863
The University of Sydney


Professor Anthony Keech is deputy director of the NHMRC Clinical Trials Centre which he joined in 1992 after time working in epidemiology at London University followed by more than five years at the Clinical Trials Research Unit and Department of Cardiology at Oxford University in the United Kingdom. He holds an NHMRC Principal Research Fellowship and is a Professor of Medicine Cardiology and Epidemiology in the Department of Medicine at the University of Sydney and a practising Consultant Cardiologist at the Royal Prince Alfred Hospital in Sydney.

Research Interest

His specialist areas are treatment strategies for acute coronary syndromes, risk factor reduction in coronary heart disease, and the non-invasive prediction of vascular disease. He has a long standing interest in lipids and heart disease, and has been a principal investigator in the Heart Protection Study, the LIPID Trial and the FIELD Trial, and immediate past Chairman of the A&NZ Cardiac Society Clinical Trials Working Group. He is a member of many national and international committees, including multinational trial steering committees, and has published widely in most of the leading medical journals.